New Filings & Updated Terms (ending 10.5.18)

This is the latest look at the IPO Pipeline including the newest filings that have registered with the SEC in the last seven days.

IPO Boutique keeps apprised of the active pipeline. Currently there are 58 active IPOs in the pipeline as of October 5,  2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.

NEW FILINGS

Company: YETI Holdings
Symbol: YETI
Description: They are a rapidly growing designer, marketer, and distributor of premium products for the outdoor and recreation market.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): BofA Merrill Lynch, Morgan Stanley, Jefferies
Co-Manager(s): Baird, Piper Jaffray, Citigroup, Goldman Sachs, KeyBanc, William Blair, Raymond James, Stifel
Filed: 9-28-18
Listed Cash Raise: $100m
Note: First filed in July 2016

Company: Revolve Group, Inc.
Symbol: RVLV
Description: REVOLVE is the next-generation fashion retailer for millennial consumers.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, Credit Suisse, BofA Merrill Lynch
Co-Manager(s): Barclays, Jefferies, Cowen, Guggenheim Securities, Raymond James, William Blair
Filed: 9-28-18
Listed Cash Raise: $100m

Company: Samoyed Holding Limited
Symbol: SMY
Description: They are the only loan facilitator in China focused on facilitating credit card balance transfer products with a weighted average APR lower than 18.25%, the annual interest rate cap for credit cards set by the PRC regulators, according to Oliver Wyman.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, Deutsche Bank, CICC
Filed: 9-28-18
Listed Cash Raise: $80m

Company: Arog Pharmaceuticals, Inc.
Symbol: AROG
Description: They are a late-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Citigroup, RBC Capital, Nomura
Filed: 9-28-18
Listed Cash Raise: $74.75m

Company: NGM Biopharmaceuticals, Inc.
Symbol: NGM
Description: They are a clinical-stage biopharmaceutical company developing novel therapeutics based on our scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic and ophthalmic diseases.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, Citigroup, Cowen
Filed: 9-28-18
Listed Cash Raise: $75m

Company: Gamida Cell Ltd.
Symbol: GMDA
Description: They are a clinical stage biopharmaceutical company leveraging our proprietary technology to develop cell therapies that are designed to cure cancer and rare, serious hematologic diseases.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): BMO Capital, RBC Capital
Co-Manager(s): Needham & Co., Oppenheimer & Co.
Filed: 9-28-18
Listed Cash Raise: $69m

Company: StoneCo Ltd.
Symbol: STNE
Description: They are a leading provider of financial technology solutions that empower merchants and integrated partners to conduct electronic commerce seamlessly across in-store, online, and mobile channels in Brazil.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, J.P. Morgan, Citigroup, Itau BBA, Credit Suisse, Morgan Stanley, BofA Merrill Lynch, BTG Pactual
Filed: 10-1-18
Listed Cash Raise: $100m

Company: Tencent Music Entertainment Group
Symbol: TME
Description: They are the largest online music entertainment platform in China, operating the top four music mobile apps in terms of mobile MAUs in the second quarter of 2018.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): BofA Merrill Lynch, Deutsche Bank, Goldman Sachs, J.P. Morgan, Morgan Stanley (ABC order)
Co-Manager(s): Allen & Co., BOCI, CICC, China Renaissance, Credit Suisse, HSBC, KeyBanc Capital, Stifel (ABC order)
Filed: 10-2-18
Listed Cash Raise: $1bn

Company: Twist Bioscience Corporation
Symbol: TWST
Description: They are a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. T
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): J.P. Morgan, Cowen
Co-Manager(s): Allen & Co., Baird
Filed: 10-3-18
Listed Cash Raise: $86.25m

Company: EnVen Energy Corporation
Symbol: ENVN
Description: They are an independent oil and natural gas company engaged in the development, exploitation, exploration and acquisition of primarily crude oil properties in the deepwater region of the U.S. Gulf of Mexico.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Citigroup, J.P. Morgan, Stifel, BMO Capital
Filed: 10-3-18
Listed Cash Raise: $100m

Company: Orchard Rx Limited
Symbol: ORTX
Description: They are a commercial-stage, fully-integrated biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): J.P. Morgan, Goldman Sachs, Cowen
Co-Manager: Wedbush PacGrow
Filed: 10-4-18
Listed Cash Raise: $172.5m

TERMS ADDED

Company: Livent Corporation
Symbol: LTHM
Description: They are a pure-play, fully integrated lithium company, with a long, proven history of producing performance lithium compounds.
New York.
Trade Date: 10/11
Shares: 20 million
Price Range: $18.00-$20.00
Underwriters: BofA Merrill Lynch, Goldman Sachs, Credit Suisse
Co-Manager(s): Citigroup, Loop Capital, Nomura
Terms Added: 10-1-18

Company: Osmotica Pharmaceuticals plc
Symbol: OSMT
Description: They are a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.
Trade Date: 10/11
Shares: 8.3 million
Price Range: $14.00-$16.00
Underwriter(s): Jefferies, Barclays, RBC, Wells Fargo
Terms Added: 10-1-18

Company: Anaplan, Inc.
Symbol: PLAN
Description: Anaplan is pioneering the category of Connected Planning, which allows organizations to transform their businesses by making better and faster decisions.
Trade Date: 10/12
Shares: 15.5 million
Price Range: $13.00-$15.00
Underwriter(s): Goldman Sachs, Morgan Stanley, Barclays
Co-Manager(s): KeyBanc Capital, Canaccord Genuity, Evercore ISI, JMP Securities, Needham & Co., Piper Jaffray, SunTrust Robinson Humphrey
Terms Added: 10-1-18

Company: Equillium, Inc.
Symbol: EQ
Description: They are a biotechnology company leveraging deep understanding of immunobiology to develop products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need.
Trade Date: 10/12
Shares: 4.67 million
Price Range: $14.00-$16.00
Underwriter(s): Jefferies, Leerink, Stifel
Terms Added: 10-2-18

Company: Allogene Therapeutics, Inc.
Symbol: ALLO
Description: They are a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer.
Trade Date: 10/11
Shares: 16 million
Price Range: $16.00-$18.00
Underwriter(s): Goldman Sachs & Co, J.P. Morgan, Cowen, Jefferies
Terms Added: 10-2-18

Company: SI-BONE, Inc.
Symbol: SIBN
Description: They are a medical device company that has pioneered a proprietary minimally invasive surgical implant system, which they call iFuse, to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain.
Trade Date: 10/18
Shares: 6 million
Price Range: $13.00-$15.00
Underwriter(s): Morgan Stanley, BofA Merrill Lynch
Co-Manager(s): Canaccord Genuity, JMP Securities
Terms Added: 10-5-18